• 1. Oxidative methods in the synthesis of vicinal di- and polycarbonyl compounds
  Viktor D. Filimonov,M S. Yusubov,Ki-Van Chi Russ. Chem. Rev. 1998 67 725

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

Recent Advances in the Application of Ethyl 2-Oxopentanoate (CAS: 50461-74-0) in Chemical Biology and Pharmaceutical Research

Ethyl 2-oxopentanoate (CAS: 50461-74-0), a key intermediate in organic synthesis, has garnered significant attention in recent chemical biology and pharmaceutical research due to its versatile applications. This compound, characterized by its keto-ester functionality, serves as a crucial building block in the synthesis of various bioactive molecules, including pharmaceuticals, agrochemicals, and flavoring agents. Recent studies have explored its role in novel synthetic pathways, metabolic engineering, and drug discovery, highlighting its potential in addressing contemporary challenges in medicinal chemistry.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of Ethyl 2-oxopentanoate in the synthesis of γ-aminobutyric acid (GABA) analogs, which are pivotal in developing neuroactive drugs. Researchers utilized this compound as a precursor in a multi-step enzymatic cascade, achieving high enantioselectivity and yield. The study underscored the compound's compatibility with biocatalytic processes, offering a sustainable alternative to traditional chemical synthesis methods. This aligns with the growing emphasis on green chemistry in pharmaceutical manufacturing.

In parallel, advancements in metabolic engineering have leveraged Ethyl 2-oxopentanoate as a metabolic intermediate in microbial production systems. A 2024 Nature Biotechnology report detailed its incorporation into engineered E. coli strains for the overproduction of branched-chain amino acids (BCAAs), which are essential in therapeutic formulations for metabolic disorders. The study highlighted the compound's role in optimizing flux through the 2-oxoacid dehydrogenase complex, demonstrating its potential in industrial biotechnology.

Furthermore, Ethyl 2-oxopentanoate has emerged as a critical reagent in fragment-based drug discovery (FBDD). Its structural motif is frequently employed in the design of kinase inhibitors, as evidenced by a 2023 ACS Chemical Biology study targeting cyclin-dependent kinases (CDKs). The keto-ester group facilitated hydrogen bonding with key residues in the ATP-binding pocket, enabling the development of selective inhibitors with nanomolar potency. This exemplifies the compound's relevance in addressing drug resistance challenges in oncology.

Recent analytical developments have also enhanced the characterization of Ethyl 2-oxopentanoate derivatives. Ultra-high-performance liquid chromatography (UHPLC) coupled with tandem mass spectrometry (MS/MS) methods, as described in a 2024 Analytical Chemistry publication, now enable precise quantification of trace impurities in pharmaceutical formulations containing this intermediate. Such advancements are critical for meeting stringent regulatory requirements in drug development.

Looking forward, the unique chemical properties of Ethyl 2-oxopentanoate position it as a valuable asset in emerging areas such as PROTAC (proteolysis-targeting chimera) technology and covalent inhibitor design. Its α-keto ester functionality offers orthogonal reactivity for targeted protein degradation strategies, as suggested by preliminary data presented at the 2024 American Chemical Society National Meeting. These developments underscore the compound's enduring relevance in cutting-edge pharmaceutical research.

• 77630-52-5(Pentanedioic acid, 2-oxo-, dibutyl ester)
• 250225-79-7(Pentanedioic acid, 2-oxo-, dipropyl ester)
• 67873-26-1(Octanoic acid, 2-oxo-, ethyl ester)
• 42212-75-9(DIETHYL 2-OXOHEPTANE-1,7-DICARBOXYLATE)
• 5753-96-8(Ethyl 2-oxohexanoate)
• 13088-50-1(Ethyl 2-oxoheptanoate)
• 35161-45-6(2-Ketocaproic acid butyl ester)
• 114318-35-3(diethyl 2,11-dioxododecanedioate)
• 5524-59-4(Ethyl 2-oxodecanoate)
• 99683-30-4(Diethyl 2-oxohexane-1,6-dicarboxylate)